{"id":21826,"date":"2025-10-10T10:38:11","date_gmt":"2025-10-10T10:38:11","guid":{"rendered":"https:\/\/glowhealth.eu\/?p=21826"},"modified":"2026-04-28T12:25:58","modified_gmt":"2026-04-28T10:25:58","slug":"juvederm-skinvive-microdroplet-technique-professional-guide","status":"publish","type":"post","link":"https:\/\/esteticaprofesional.shop\/?p=21826","title":{"rendered":"JUV\u00c9DERM\u00ae SKINVIVE&#x2122; for Skin Quality: Microdroplet Technique, Patient Selection, Dosing, and Safety (A Professional Guide)"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">In accordance with <strong>Law 34\/1988 on Advertising<\/strong> and <strong>Royal Decree 1591\/2009<\/strong> on medical devices, the information in this article is <strong>intended exclusively for healthcare professionals<\/strong>. Its content is <strong>not aimed at the general public<\/strong> and <strong>should not be used<\/strong> as a basis for self-medication or for making clinical decisions without professional supervision.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/glowhealth.eu\/?s=+Juvederm&amp;post_type=product&amp;dgwt_wcas=1\" data-type=\"link\" data-id=\"https:\/\/glowhealth.eu\/?s=+Juvederm&amp;post_type=product&amp;dgwt_wcas=1\" target=\"_blank\" rel=\"noopener\">Juv\u00e9derm<\/a><\/strong> is one of the most recognized <strong>dermal filler brands<\/strong> worldwide, used in aesthetic medicine for <strong>facial rejuvenation<\/strong> and <strong>volume enhancement<\/strong> in specific areas of the face. Its <strong>hyaluronic acid\u2013based formula<\/strong> delivers hydration, firmness, and natural-looking results. Among its advanced products, <strong><a href=\"https:\/\/glowhealth.eu\/es\/product\/juvederm-volite-with-lidocaine-12mg-ml-3mg-ml-2-1ml-prefilled-syringes\" data-type=\"link\" data-id=\"https:\/\/glowhealth.eu\/es\/product\/juvederm-volite-with-lidocaine-12mg-ml-3mg-ml-2-1ml-prefilled-syringes\" target=\"_blank\" rel=\"noopener\">Juvederm Skinvive<\/a><\/strong> stands out for improving <strong>skin quality and radiance<\/strong> without adding volume. In this article, we analyze expert <strong>opinions on Juv\u00e9derm<\/strong>, its <strong>benefits<\/strong>, <strong>clinical outcomes<\/strong>, and <strong>comparisons with other injectable treatments<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">1) What SKINVIVE&#x2122; by JUV\u00c9DERM\u00ae <em>is<\/em> (and what it is not)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Definition &amp; indication (U.S.):<\/strong> SKINVIVE is an <strong>intradermal HA microdroplet<\/strong> injectable indicated to improve <strong>cheek skin smoothness<\/strong> in adults (\u226521). Official pages:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Main site: <a>https:\/\/www.skinvivebyjuvederm.com\/<\/a><\/li>\n\n\n\n<li>Corporate brand page: <a>https:\/\/www.allerganaesthetics.com\/brands\/skinvive<\/a><\/li>\n\n\n\n<li>FDA device summary: <a>https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/skinvive-juvederm-p110033s059<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Mechanism of value:<\/strong> Unlike volumizing HA fillers, SKINVIVE targets the <strong>superficial dermis<\/strong> using <strong>micro-aliquots<\/strong> to enhance <strong>hydration<\/strong>, <strong>light reflection (radiance)<\/strong>, and <strong>perceived smoothness<\/strong> without changing contours. This aligns with broader HA skin-quality evidence: <a>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10082573\/<\/a> .<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Key durability datapoint:<\/strong> Patient-reported outcomes and clinical scales show <strong>benefit through ~6 months<\/strong> with optimal treatment. See brand page language and pivotal data summary: <a>https:\/\/www.allerganaesthetics.com\/brands\/skinvive<\/a> ; SSED: <a>https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf11\/P110033S059B.pdf<\/a> .<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Composition and anesthetic:<\/strong> The FDA page describes HA crosslinked with <strong>BDDE<\/strong> and <strong>0.3% lidocaine<\/strong> to reduce injection pain: <a>https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/skinvive-juvederm-p110033s059<\/a> .<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Not for volumization or lifting:<\/strong> The target outcome is <strong>skin quality<\/strong> (smoothness, glow, hydration), not projection or structural lifting. This \u201cnon-volumizing\u201d positioning reduces confusion versus Voluma\/Volux (contour) or Ultra\/Volift\/Volbella (lines\/lips).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">2) Patient selection and objective setting<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ideal candidates<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Adults with <strong>fine textural irregularities<\/strong>, dullness, or early laxity primarily visible on the <strong>cheeks<\/strong>.<\/li>\n\n\n\n<li>Phototypes I\u2013VI; adjust technique and aftercare for higher phototypes per clinic protocol.<\/li>\n\n\n\n<li>Patients who want <strong>\u201cglow\u201d<\/strong> and <strong>smoother texture<\/strong> without obvious volume change.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Relative cautions\/contraindications (summarize; defer to DFU\/IFU and local regulations):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Active infection\/inflammation at site; hypersensitivity to HA\/lidocaine; bleeding disorders; pregnancy\/lactation (per clinic policy).<\/li>\n\n\n\n<li>Medications increasing bleeding risk (anticoagulants\/NSAIDs) warrant risk discussion. See PIL\/IFU: <a>https:\/\/www.allerganaesthetics.com.au\/content\/dam\/aa-corporate\/au\/en\/pdf\/SkinVive_by_Juvederm-PIL-v2.0.pdf<\/a> .<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Expectation management<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Set a <strong>\u201cskin-quality\u201d<\/strong> goal (smoothness, hydration, radiance), not line effacement equal to mid\/deep dermal fillers.<\/li>\n\n\n\n<li>Clarify the <strong>maintenance<\/strong> horizon (~6 months) and need for touch-ups per response.<\/li>\n\n\n\n<li>Discuss potential visible <strong>papules<\/strong> immediately post-procedure (transient), edema, and bruising\u2014typical of intradermal microdroplets; provide aftercare. DFU: <a>https:\/\/www.rxabbvie.com\/pdf\/skinvive_dfu.pdf<\/a> .<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">3) Treatment planning: zones, planes, and spacing<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Indication focus:<\/strong> <strong>Cheeks (malar\/submalar skin)<\/strong> per U.S. label. See FDA: <a>https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/skinvive-juvederm-p110033s059<\/a> and brand page: <a>https:\/\/www.allerganaesthetics.com\/brands\/skinvive<\/a> .<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Plane:<\/strong> <strong>Intradermal<\/strong>. Fine-gauge needle (e.g., <strong>32G<\/strong>). Source DFU: <a>https:\/\/www.rxabbvie.com\/pdf\/skinvive_dfu.pdf<\/a> .<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pattern\/spacing (principles):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Multiple <strong>micro-aliquots<\/strong> (microdroplets) distributed evenly across the cheek skin envelope.<\/li>\n\n\n\n<li>Maintain steady, <strong>slow injections<\/strong>, micro volumes per deposit; avoid bolus volume.<\/li>\n\n\n\n<li>Respect safety in <strong>thin dermis<\/strong> or post-inflammatory skin\u2014reduce aliquot size and spacing.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Dosing framework (orientation for planning; tailor to label, training, and patient response):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Many injectors plan the cheek area using <strong>grids<\/strong> of microdroplets (e.g., 0.01\u20130.02 mL per point) spaced <strong>~1 cm<\/strong> apart; total <strong>per cheek<\/strong> varies with skin quality (clinic protocol dependent).<\/li>\n\n\n\n<li>Consider a <strong>touch-up<\/strong> at ~1 month for non-responders or to optimize uniformity, consistent with DFU discussion of responder rates over time: <a>https:\/\/www.rxabbvie.com\/pdf\/skinvive_dfu.pdf<\/a> (see outcomes and instructions).<\/li>\n<\/ul>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Tip:<\/strong> For patients with mixed needs (e.g., contour + skin quality), stage treatments\u2014<strong>volumize first<\/strong>, allow integration and edema resolution, then <strong>skin-quality microdroplets<\/strong>. This sequencing improves photographic clarity and patient satisfaction.<\/p>\n<\/blockquote>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">4) Technique: needles, cannulas, and intradermal accuracy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Needle vs cannula:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The DFU emphasizes a <strong>fine-gauge needle<\/strong> (e.g., 32G) for intradermal placement: <a>https:\/\/www.rxabbvie.com\/pdf\/skinvive_dfu.pdf<\/a> .<\/li>\n\n\n\n<li>Cannulas are less typical for superficial intradermal microdroplets (risk of incorrect plane). If using cannulas in select cases, ensure true intradermal positioning and micro-aliquots\u2014<strong>avoid linear threading<\/strong> that could lead to uneven distribution or visibility.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Verification of intradermal plane:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Dermal bleb<\/strong>\/papule immediately visible and <strong>blanches<\/strong> lightly then settles.<\/li>\n\n\n\n<li>If resistance is low and product \u201cdisappears,\u201d you may be too deep; if whitening\/pain is disproportionate, reassess plane and aspiration policy per clinic safety SOP.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Comfort &amp; hemostasis:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Lidocaine 0.3% in product improves comfort (FDA page: <a>https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/skinvive-juvederm-p110033s059<\/a> ).<\/li>\n\n\n\n<li>Pre-cooling and brief post-pressure help reduce bruising. Avoid high compression that may displace microdroplets.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">5) Safety profile and complication management<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Expected minor AEs:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Transient <strong>papules<\/strong>, <strong>erythema<\/strong>, <strong>edema<\/strong>, <strong>pruritus<\/strong>, and <strong>ecchymosis<\/strong> are common and typically self-limited. DFU\/IFU: <a>https:\/\/www.rxabbvie.com\/pdf\/skinvive_dfu.pdf<\/a> ; <a>https:\/\/www.allerganaesthetics.com.au\/content\/dam\/aa-corporate\/au\/en\/pdf\/SkinVive_by_Juvederm-IFU.pdf<\/a> .<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Less common events:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Persistent papules<\/strong> (often technique\/plane related), <strong>Tyndall-like hue<\/strong> if too superficial, <strong>nodularity<\/strong> (rare with proper microdroplets).<\/li>\n\n\n\n<li><strong>Delayed inflammatory reactions<\/strong> and biofilm-related events are uncommon but recognized across HA fillers; see broader HA literature: <a>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10082573\/<\/a> .<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ischemic risk context:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Intradermal microdeposits in the cheek have <strong>lower<\/strong> ischemic risk than deep bolus in high-risk zones; nonetheless, maintain standard vascular safety protocols (aspiration policy per SOP, slow injection, low pressure). For background on HA filler vascular events, see review: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6128162\/?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6128162\/<\/a> (general HA context).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hyaluronidase readiness:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Stock per protocol with <strong>dose algorithms<\/strong> for intradermal over-correction, visible papules unresolving, or suspected intravascular compromise (rare). Create a <strong>hyaluronidase quick-reference<\/strong> by scenario; consult local guidance and product labeling.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Aftercare counseling:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Avoid vigorous massage, extremes of heat\/sauna, and strenuous exercise for 24\u201348h; follow your clinic\u2019s post-care leaflets. Align with DFU: <a>https:\/\/www.rxabbvie.com\/pdf\/skinvive_dfu.pdf<\/a> .<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">6) Evidence highlights (durability, outcomes, and PROs)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Regulatory, labeling &amp; trial summary (U.S.):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>FDA approval announcement (May 15, 2023): <a>https:\/\/www.prnewswire.com\/news-releases\/skinvive-by-juvederm-receives-us-fda-approval-301824129.html<\/a><\/li>\n\n\n\n<li>FDA device summary page: <a>https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/skinvive-juvederm-p110033s059<\/a><\/li>\n\n\n\n<li>FDA SSED (pivotal data overview): <a>https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf11\/P110033S059B.pdf<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Durability &amp; PROs:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Brand data: <strong>up to 6 months<\/strong> with optimal treatment and higher satisfaction with glow\/hydration\/healthy look in a clinical study: <a>https:\/\/www.allerganaesthetics.com\/brands\/skinvive<\/a> ; consumer-facing summary: <a>https:\/\/www.skinvivebyjuvederm.com\/about-skinvive<\/a> .<\/li>\n\n\n\n<li>HA skin-quality literature consistently reports gains in hydration, texture, and radiance with intradermal HA across products (systematic review): <a>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10082573\/<\/a> .<\/li>\n\n\n\n<li>VYC-12 (Volite) literature shows maintenance <strong>up to 6 months<\/strong>\u2014useful background when counseling about the likely maintenance horizon for skin-quality HA: <a>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6817835\/<\/a> and clinical experience paper: <a>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8493242\/<\/a> .<\/li>\n<\/ul>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Clinical inference:<\/strong> While SKINVIVE\u2019s U.S. label centers on cheeks, the <strong>skin-quality<\/strong> paradigm (microdroplet intradermal HA) is transferable in principle to similar broader skin envelopes with appropriate evidence and regulatory alignment. Monitor label updates\u2014e.g., sPMA accepted for <strong>neck lines<\/strong> review (not yet an approval): <a>https:\/\/news.abbvie.com\/2025-06-30-U-S-Food-and-Drug-Administration-Accepts-for-Review-Allergan-Aesthetics-Premarket-Approval-Application-for-SKINVIVE-by-JUVEDERM-R-for-the-Improvement-of-Neck-Appearance<\/a>.<\/p>\n<\/blockquote>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/glowhealth.eu\/wp-content\/uploads\/2025\/10\/juvederm-skinvive-intradermal-injection-plane-diagram-1024x683.jpg\" alt=\"Aesthetic medicine professional performing Juvederm Skinvive microdroplet injection on the cheek using a fine needle.\" class=\"wp-image-21828\" srcset=\"https:\/\/glowhealth.eu\/wp-content\/uploads\/2025\/10\/juvederm-skinvive-intradermal-injection-plane-diagram-980x653.jpg 980w, https:\/\/glowhealth.eu\/wp-content\/uploads\/2025\/10\/juvederm-skinvive-intradermal-injection-plane-diagram-480x320.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><figcaption class=\"wp-element-caption\">Clinical demonstration of Juvederm Skinvive microdroplet injection technique performed on the cheek.<\/figcaption><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">7) Practical protocol: planning &amp; dosing table (orientation)<\/h2>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Important:<\/strong> Always align dosing to your <strong>training, IFU\/DFU<\/strong>, patient characteristics, and local regulations. The following is an <strong>orientation framework<\/strong> to structure planning conversations\u2014not a substitute for official instructions.<\/p>\n<\/blockquote>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Planning element<\/th><th>Practical orientation for cheeks<\/th><\/tr><\/thead><tbody><tr><td>Objective<\/td><td>Skin smoothness, hydration, radiance (no contour change)<\/td><\/tr><tr><td>Plane<\/td><td><strong>Intradermal<\/strong><\/td><\/tr><tr><td>Needle<\/td><td>Fine gauge (e.g., <strong>32G<\/strong>) per DFU<\/td><\/tr><tr><td>Pattern<\/td><td>Even <strong>microdroplets<\/strong> distributed across the malar\/submalar envelope<\/td><\/tr><tr><td>Aliquot per droplet<\/td><td>~0.01\u20130.02 mL (adjust for dermal thickness\/phototype)<\/td><\/tr><tr><td>Spacing<\/td><td>~1 cm between deposits (adapt to coverage and dermal thickness)<\/td><\/tr><tr><td>Total per cheek<\/td><td>Adjust to skin envelope size and baseline quality; many injectors plan a grid and titrate to <strong>clinical endpoints<\/strong> (glow\/texture)<\/td><\/tr><tr><td>Touch-up<\/td><td>Consider at ~<strong>4 weeks<\/strong> if needed for uniformity<\/td><\/tr><tr><td>Maintenance<\/td><td>Expect <strong>~6 months<\/strong> (optimize lifestyle\/skin care)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Sources for technique context: DFU: <a>https:\/\/www.rxabbvie.com\/pdf\/skinvive_dfu.pdf<\/a> ; brand\/label pages: <a>https:\/\/www.allerganaesthetics.com\/brands\/skinvive<\/a> ; FDA page: <a>https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/skinvive-juvederm-p110033s059<\/a> .<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">8) Combining SKINVIVE with other procedures (sequencing)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>With volumizing HA fillers (<a href=\"https:\/\/glowhealth.eu\/product\/juvederm-voluma-with-lidocaine-20mg-ml-3mg-ml-2-1ml-prefilled-syringes\/\" data-type=\"link\" data-id=\"https:\/\/glowhealth.eu\/product\/juvederm-voluma-with-lidocaine-20mg-ml-3mg-ml-2-1ml-prefilled-syringes\/\" target=\"_blank\" rel=\"noopener\">Voluma<\/a>\/<a href=\"https:\/\/glowhealth.eu\/product\/juvederm-volux-with-lidocaine-2-1ml-pre-filled-syringes\/\" data-type=\"link\" data-id=\"https:\/\/glowhealth.eu\/product\/juvederm-volux-with-lidocaine-2-1ml-pre-filled-syringes\/\" target=\"_blank\" rel=\"noopener\">Volux<\/a>\/<a href=\"https:\/\/glowhealth.eu\/product\/juvederm-volift-w-lidocaine-17-5mg-ml-3mg-ml-2-1ml-prefilled-syringes\/\" data-type=\"link\" data-id=\"https:\/\/glowhealth.eu\/product\/juvederm-volift-w-lidocaine-17-5mg-ml-3mg-ml-2-1ml-prefilled-syringes\/\" target=\"_blank\" rel=\"noopener\">Volift<\/a>, etc.):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sequence:<\/strong> volumization\/contour first \u2192 integrate (2\u20134 weeks) \u2192 <strong>SKINVIVE<\/strong> for skin-quality finish.<\/li>\n\n\n\n<li>Rationale: clarity in photographic outcomes; avoids confounding edema with skin-quality readouts.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>With energy-based devices (laser\/RF):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Prefer <strong>EBL before<\/strong> or <strong>after a suitable interval<\/strong> post-injection per device type and clinic policy.<\/li>\n\n\n\n<li>Microdroplets are superficial; <strong>thermal insult<\/strong> too soon may alter integration. Document your washout periods in SOP.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>With biostimulatory agents (CaHA, PLLA) or Profhilo\/Skinboosters:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Either <strong>hybrid<\/strong> (staged) or <strong>sequential<\/strong> strategies, but avoid stacking treatments too close.<\/li>\n\n\n\n<li>Keep the message clear: SKINVIVE = <strong>skin quality<\/strong>; volumizers\/biostimulators = <strong>structure\/elasticity<\/strong>.<\/li>\n<\/ul>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Always follow the <strong>product labels<\/strong>, your <strong>training<\/strong>, and manufacturer guidance. For JUV\u00c9DERM\u00ae collection overview (official): <a>https:\/\/www.juvederm.com\/<\/a> and corporate page: <a>https:\/\/www.allerganaesthetics.com\/brands\/juvederm<\/a> .<\/p>\n<\/blockquote>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">9) Counseling and aftercare (practitioner checklist)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Before the appointment:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Align <strong>objectives<\/strong>: \u201cglow\/smoothness\u201d vs \u201cvolume\/lift.\u201d<\/li>\n\n\n\n<li>Review <strong>medical history<\/strong>, photosensitive disorders, recent procedures, and meds affecting hemostasis.<\/li>\n\n\n\n<li>Obtain informed consent specific to <strong>intradermal microdroplets<\/strong> (papules, bruising, expected timeline).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>During injection:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Confirm <strong>intradermal<\/strong> plane visually; micro-aliquots with even spacing.<\/li>\n\n\n\n<li>Slow injection; minimal pressure; monitor patient comfort.<\/li>\n\n\n\n<li>Stop if disproportionate pain\/whitening\u2014reassess plane and vascular safety SOP.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Aftercare basics:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>No strenuous exercise, heat exposure, or intense facial massage for 24\u201348h.<\/li>\n\n\n\n<li>Gentle skincare; avoid actives (AHA\/BHA\/retinoids) for ~24\u201348h if sensitive.<\/li>\n\n\n\n<li>Educate on <strong>expected papules<\/strong> (transient), bruising, and when to contact the clinic.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>When to review:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Re-assess at <strong>~4 weeks<\/strong> for uniformity and consider touch-up if indicated.<\/li>\n\n\n\n<li>Plan <strong>maintenance<\/strong> at ~6 months depending on response, photodamage, and patient goals.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">10) Documentation &amp; photography<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Use <strong>standardized lighting<\/strong> and <strong>polarized\/non-polarized<\/strong> shots to highlight changes in <strong>texture and light scatter<\/strong>.<\/li>\n\n\n\n<li>Record <strong>grid pattern<\/strong>, total volume per cheek, needle, and any deviations.<\/li>\n\n\n\n<li>Capture <strong>patient-reported outcomes<\/strong> (glow, hydration, smoothness) at baseline and follow-up\u2014these correlate strongly with satisfaction in skin-quality treatments.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">11) Advanced considerations<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ultrasound (POCUS) in skin-quality injections:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>While intradermal targets are superficial, <strong>ultrasound<\/strong> can assist in <strong>planning<\/strong> (vascular mapping) in complex cases or in troubleshooting persistent papules vs malposition.<\/li>\n\n\n\n<li>Build an internal library of sonographic appearances post-microdroplet injections for your QA meetings.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Higher phototypes:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Adjust spacing\/aliquot size; minimize trauma. Consider post-care that reduces PIH risk (clinic SOP).<\/li>\n\n\n\n<li>Ensure photography settings avoid <strong>false gloss<\/strong> that overstates \u201cglow.\u201d<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Neck\/Off-face exploration:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Track official label updates: FDA acceptance for <strong>neck lines<\/strong> sPMA is under <strong>review<\/strong> (not an approval): <a>https:\/\/news.abbvie.com\/2025-06-30-U-S-Food-and-Drug-Administration-Accepts-for-Review-Allergan-Aesthetics-Premarket-Approval-Application-for-SKINVIVE-by-JUVEDERM-R-for-the-Improvement-of-Neck-Appearance<\/a> . Maintain on-label use until local approvals change.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">12) Frequently asked questions (for professionals)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Q1. How is SKINVIVE different from Volite or Redensity I?<\/strong><br>All target <strong>skin quality<\/strong> via <strong>intradermal<\/strong> HA, but <strong>formulations, rheology, and labels<\/strong> differ by brand and market. SKINVIVE is the <strong>first FDA-approved<\/strong> HA microdroplet injectable for <strong>cheek skin smoothness<\/strong> in the U.S. (label specificity). Sources: <a>https:\/\/www.allerganaesthetics.com\/brands\/skinvive<\/a> ; FDA device page: <a>https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/skinvive-juvederm-p110033s059<\/a> ; broader HA literature: <a>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10082573\/<\/a> .<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Q2. What durability can patients expect?<\/strong><br>About <strong>6 months<\/strong> with optimal treatment (plan maintenance accordingly). Sources: <a>https:\/\/www.allerganaesthetics.com\/brands\/skinvive<\/a> ; <a>https:\/\/www.skinvivebyjuvederm.com\/about-skinvive<\/a> .<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Q3. Can I combine SKINVIVE with volumizing fillers in one session?<\/strong><br>Prefer <strong>staging<\/strong> (structure first, then skin quality) for clarity and safety. Follow DFU and brand training guidance; see DFU here: <a>https:\/\/www.rxabbvie.com\/pdf\/skinvive_dfu.pdf<\/a> .<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Q4. What\u2019s the biggest technique mistake?<\/strong><br>Leaving the <strong>intradermal plane<\/strong>\u2014going too deep diminishes the skin-quality effect; too superficial risks visible product\/papules. Use <strong>tiny aliquots<\/strong> and <strong>even spacing<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Q5. Do I need hyaluronidase on hand?<\/strong><br>Yes\u2014per your clinic\u2019s emergency protocols for HA fillers. Maintain SOPs for <strong>over-correction, visible malposition<\/strong>, or rare vascular concerns (general HA safety literature: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6128162\/?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6128162\/<\/a> ).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">15) References (official\/authoritative; visible URLs)<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>SKINVIVE by JUV\u00c9DERM\u00ae\u2014Official site<\/strong> (Indication, consumer-facing overview)<br><a href=\"https:\/\/www.skinvivebyjuvederm.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.skinvivebyjuvederm.com\/<\/a><\/li>\n\n\n\n<li><strong>Allergan Aesthetics\u2014SKINVIVE brand page<\/strong> (corporate overview, claims, PROs)<br><a href=\"https:\/\/www.allerganaesthetics.com\/brands\/skinvive\" target=\"_blank\" rel=\"noopener\">https:\/\/www.allerganaesthetics.com\/brands\/skinvive<\/a><\/li>\n\n\n\n<li><strong>FDA\u2014Recently Approved Devices: SKINVIVE by JUV\u00c9DERM (P110033\/S059)<\/strong> (device summary, composition)<br><a href=\"https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/skinvive-juvederm-p110033s059\" target=\"_blank\" rel=\"noopener\">https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/skinvive-juvederm-p110033s059<\/a><\/li>\n\n\n\n<li><strong>FDA\u2014SSED PDF for SKINVIVE (P110033\/S059)<\/strong> (trial design and outcomes)<br><a href=\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf11\/P110033S059B.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf11\/P110033S059B.pdf<\/a><\/li>\n\n\n\n<li><strong>Allergan\/AbbVie\u2014Press release (FDA approval, May 15, 2023)<\/strong><br><a href=\"https:\/\/www.prnewswire.com\/news-releases\/skinvive-by-juvederm-receives-us-fda-approval-301824129.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.prnewswire.com\/news-releases\/skinvive-by-juvederm-receives-us-fda-approval-301824129.html<\/a><\/li>\n\n\n\n<li><strong>Allergan\/AbbVie\u2014Newsroom (sPMA acceptance for neck lines, June 30, 2025)<\/strong><br><a href=\"https:\/\/news.abbvie.com\/2025-06-30-U-S-Food-and-Drug-Administration-Accepts-for-Review-Allergan-Aesthetics-Premarket-Approval-Application-for-SKINVIVE-by-JUVEDERM-R-for-the-Improvement-of-Neck-Appearance\" target=\"_blank\" rel=\"noopener\">https:\/\/news.abbvie.com\/2025-06-30-U-S-Food-and-Drug-Administration-Accepts-for-Review-Allergan-Aesthetics-Premarket-Approval-Application-for-SKINVIVE-by-JUVEDERM-R-for-the-Improvement-of-Neck-Appearance<\/a><\/li>\n\n\n\n<li><strong>RxAbbVie\u2014U.S. DFU for SKINVIVE (Instructions\/DFU PDF)<\/strong><br>https:\/\/www.rxabbvie.com\/pdf\/skinvive_dfu.pdf<\/li>\n\n\n\n<li><strong>Allergan Aesthetics AU\u2014IFU &amp; PIL (regional practitioner and patient info)<\/strong><br><a href=\"https:\/\/www.allerganaesthetics.com.au\/content\/dam\/aa-corporate\/au\/en\/pdf\/SkinVive_by_Juvederm-IFU.pdf\nhttps:\/\/www.allerganaesthetics.com.au\/content\/dam\/aa-corporate\/au\/en\/pdf\/SkinVive_by_Juvederm-PIL-v2.0.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.allerganaesthetics.com.au\/content\/dam\/aa-corporate\/au\/en\/pdf\/SkinVive_by_Juvederm-IFU.pdf<br>https:\/\/www.allerganaesthetics.com.au\/content\/dam\/aa-corporate\/au\/en\/pdf\/SkinVive_by_Juvederm-PIL-v2.0.pdf<\/a><\/li>\n\n\n\n<li><strong>Systematic review\u2014HA injectables and skin quality (Open Access)<\/strong><br><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10082573\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10082573\/<\/a><\/li>\n\n\n\n<li><strong>VYC-12 (Volite) clinical study\u2014durability up to 6 months<\/strong><br><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6817835\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6817835\/<\/a><\/li>\n\n\n\n<li><strong>Volite clinical experience\u2014safety &amp; maintenance<\/strong><br><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8493242\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8493242\/<\/a><\/li>\n\n\n\n<li><strong>JUV\u00c9DERM\u00ae Collection (official overview)<\/strong><br><a href=\"https:\/\/www.juvederm.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.juvederm.com\/<\/a><br><a href=\"https:\/\/www.allerganaesthetics.com\/brands\/juvederm\" target=\"_blank\" rel=\"noopener\">https:\/\/www.allerganaesthetics.com\/brands\/juvederm<\/a><\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n","protected":false},"excerpt":{"rendered":"<p>Aliaxin es un relleno d\u00e9rmico de \u00e1cido hialur\u00f3nico dise\u00f1ado para la restauraci\u00f3n del volumen facial, la hidrataci\u00f3n profunda de la piel y la reducci\u00f3n de arrugas. Gracias a su avanzada formulaci\u00f3n, se integra de manera natural con los tejidos, proporcionando resultados duraderos y de aspecto natural.<\/p>\n","protected":false},"author":26,"featured_media":21827,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[107],"tags":[2537,3233,2852,2536,2564,2545,3234,114,3231,3241,3240,3242,3236,3237,3232,2574,3235,3238,2546,3239],"class_list":["post-21826","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-juvederm","tag-aesthetic-medicine","tag-allergan-aesthetics","tag-dermal-filler-safety","tag-facial-rejuvenation","tag-hyaluronic-acid-fillers","tag-hyaluronic-acid-injection","tag-intradermal-injections","tag-juvederm","tag-juvederm-skinvive","tag-juvederm-skinvive-benefits","tag-juvederm-skinvive-for-cheeks","tag-juvederm-skinvive-professional-guide","tag-juvederm-skinvive-results","tag-juvederm-skinvive-technique","tag-microdroplet-technique","tag-non-surgical-facial-treatments","tag-professional-injectables","tag-skin-hydration","tag-skin-quality-treatment","tag-skin-smoothness-improvement"],"_links":{"self":[{"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=\/wp\/v2\/posts\/21826","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21826"}],"version-history":[{"count":4,"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=\/wp\/v2\/posts\/21826\/revisions"}],"predecessor-version":[{"id":23375,"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=\/wp\/v2\/posts\/21826\/revisions\/23375"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=\/wp\/v2\/media\/21827"}],"wp:attachment":[{"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/esteticaprofesional.shop\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}